OSCR Oscar Health, Inc.

company

SEC Filings & Insider Trading Activity 2026

Business Overview

• • Core business model: Technology-enabled health insurer offering ACA individual market plans with integrated full stack platform and focus on member experience
• • New 2025 acquisitions: Lucie (enrollment tech), IHC Specialty Benefits (brokerage), Healthinsurance.org, expanding ICHRA capabilities and consumer health marketplace
• • Strategic shift: Exited Cigna+Oscar Small Group partnership, intensified focus on growing ICHRA and individual market channels with proprietary tech and expanded broker/enrollment services
• • Membership growth: Total effectuated members increased 22% YoY to ~2.0 million, with Florida membership surging 35% to 1.18 million in 2025
• • Noteworthy: +Oscar’s Campaign Builder platform now serves nearly 0.6 million client lives, underscoring growth of Oscar’s technology-powered B2B engagement segment

Risk Factors

• • Debt obligations under 2030 Convertible Senior Notes $410M pose liquidity risk on mandatory repurchase or conversion payments
• • $475M secured 3-year revolving credit facility with JPMorgan Chase began Feb 2026 replacing terminated $115M facility
• • Requirement to maintain restricted investments in U.S. Treasury securities and cash for state licensure limits liquidity flexibility
• • Operating cash flow impacted by timing and size of large insurance claim payments and risk adjustment transfers
• • Convertible notes issuance proceeds $410M increased financing cash by $399.2M in 2025 vs $68.4M in 2024

Management Discussion & Analysis

• • Total revenue $X (amount not specified), driven by Premium revenue and investment income components
• • Operating loss and net loss figures not disclosed; MLR and SG&A ratios provided but no % margin change specified
• • Membership grew to approx. 2.0 million effectuated members as of Dec 31, 2025; impact of Medicaid redeterminations aided 2024 growth, limited in 2025
• • No specific cash flow, buybacks, dividends, or capex amounts detailed in the excerpt
• • Regulatory risks include expiration of enhanced Advanced Premium Tax Credits (eAPTCs) end of 2025 and new CMS Program Integrity Rules affecting enrollment and Advanced Premium Tax Credit eligibility

What are the latest OSCR SEC filings in 2026?

Oscar Health, Inc. (OSCR) has filed a 10-K annual report on February 13, 2026, a 10-Q quarterly report on May 7, 2026, an 8-K current report on August 6, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.

When did OSCR file its most recent 10-K annual report?

Oscar Health, Inc. (OSCR) filed its most recent 10-K annual report on February 13, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.

How do I view OSCR 10-Q quarterly reports?

Oscar Health, Inc. (OSCR)'s most recent 10-Q quarterly report was filed on May 7, 2026. SignalX displays every OSCR 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.

What 8-K current reports has OSCR filed recently?

Oscar Health, Inc. (OSCR)'s most recent 8-K was filed on August 6, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.

Where can I find OSCR insider trading activity (Form 4)?

SignalX aggregates every OSCR Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.

How often does OSCR file with the SEC?

Oscar Health, Inc. (OSCR) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new OSCR filing with AI-powered analysis.

What is the difference between 10-K, 10-Q, and 8-K SEC filings?

A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Oscar Health, Inc. (OSCR).

What is OSCR's SEC CIK number?

Oscar Health, Inc. (OSCR)'s SEC CIK (Central Index Key) number is 1568651. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1568651 to look up all OSCR filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.

Where can I find OSCR return on equity (ROE) and financial data?

SignalX extracts XBRL financial data from Oscar Health, Inc. (OSCR) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.